These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8397131)

  • 1. HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.
    Okuda M
    Gastroenterol Jpn; 1993 Aug; 28(4):535-40. PubMed ID: 8397131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA.
    Muratori L; Giostra F; Cataleta M; Francesconi R; Ballardini G; Cassani F; Lenzi M; Bianchi FB
    Liver; 1994 Jun; 14(3):124-8. PubMed ID: 8078391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon.
    Ounanian A; Gueddah N; Rolachon A; Thelu MA; Zarski JP; Seigneurin JM
    J Med Virol; 1995 Feb; 45(2):141-5. PubMed ID: 7775931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells.
    Willems M; Peerlinck K; Moshage H; Deleu I; Van den Eynde C; Vermylen J; Yap SH
    J Med Virol; 1994 Mar; 42(3):272-8. PubMed ID: 7516421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment.
    Peerlinck K; Willems M; Sheng L; Nevens F; Fevery J; Yap SH; Vermylen J
    Br J Haematol; 1994 Apr; 86(4):816-9. PubMed ID: 7918078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C.
    Yun ZB; Sönnerborg A; Weiland O
    Scand J Gastroenterol; 1994 Jan; 29(1):82-6. PubMed ID: 8128182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment.
    Taliani G; Badolato C; Lecce R; Poliandri G; Bozza A; Duca F; Pasquazzi C; Clementi C; Furlan C; De Bac C
    J Med Virol; 1995 Sep; 47(1):16-22. PubMed ID: 8551253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy.
    Hino K; Okuda M; Konishi T; Ishiko H; Okita K
    Dig Dis Sci; 1995 Jan; 40(1):14-20. PubMed ID: 7821101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
    Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
    J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
    Orito E; Mizokami M; Suzuki K; Ohba KI; Ohno T; Mizuno M; Iijima Y; Saito H; Nemoto A; Nukuta N
    J Gastroenterol Hepatol; 1997 Jan; 12(1):58-61. PubMed ID: 9076625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicative level of hepatitis C virus (HCV) in chronic hepatitis C.
    Hayashi N; Kamada T
    Intern Med; 1993 Dec; 32(12):944-5. PubMed ID: 8204979
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
    Schmidt WN; Wu P; Brashear D; Klinzman D; Phillips MJ; LaBrecque DR; Stapleton JT
    Hepatology; 1998 Oct; 28(4):1110-6. PubMed ID: 9755250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
    Kondo M; Tanaka K; Ikeda M; Arata S; Saito S; Sakaguchi T; Morimoto M; Fujii T; Mitsui K; Okazaki H; Hoshino M; Sekihara H
    J Gastroenterol Hepatol; 1996 Mar; 11(3):236-40. PubMed ID: 8742919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of persistence of IFN-alpha treatment response in chronic hepatitis C patients according with HCV-RNA presence in PBMC].
    Piekarska A; Sidorkiewicz M; Lewandowska U; Kuydowicz J
    Pol Arch Med Wewn; 2001 Oct; 106(4):939-44. PubMed ID: 11993413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.